ORIGINAL RESEARCH article
Front. Mol. Biosci., 04 July 2022
Sec. Molecular Diagnostics and Therapeutics
Volume 9 - 2022 | https://doi.org/10.3389/fmolb.2022.860525
RETRACTED: Identification of a Novel Ferroptosis Inducer for Gastric Cancer Treatment Using Drug Repurposing Strategy
Jinping Zhang 1
Meimei Gao 2
Ying Niu 1
Jiangang Sun 3*
1. Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2. Henan Key Laboratory of Precision Clinical Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
3. Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Summary
Citation
Zhang J, Gao M, Niu Y and Sun J (2022) RETRACTED: Identification of a Novel Ferroptosis Inducer for Gastric Cancer Treatment Using Drug Repurposing Strategy. Front. Mol. Biosci. 9:860525. doi: 10.3389/fmolb.2022.860525
Received
23 January 2022
Accepted
07 June 2022
Published
04 July 2022
Volume
9 - 2022
Edited by
Gilbert O. Fruhwirth, King’s College London, United Kingdom
Reviewed by
Hironobu Yasui, Hokkaido University, Japan
Flavia Biamonte, Magna Græcia University of Catanzaro, Italy
Weiguang Sun, Huazhong University of Science and Technology, China
Zhimei Li, Northwestern Polytechnical University, China
Updates
This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.